Kidney disease drug trial pulled before it began
NCT ID NCT06489340
First seen Nov 01, 2025 · Last updated May 10, 2026 · Updated 28 times
Summary
This study aimed to test an experimental drug called VAR200 in adults with type 2 diabetes and kidney disease. The goal was to see if the drug could reduce protein in the urine, a sign of kidney damage. However, the trial was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Advancement Center, PLLC
San Antonio, Texas, 78212, United States
Conditions
Explore the condition pages connected to this study.